738P Quality-adjusted time without symptom or toxicity (QA-TWiST) and quality-adjusted progression-free survival (QA-PFS) of first-line (1L) maintenance niraparib in patients with advanced ovarian cancer (OC): Results from the PRIMA trial
医学
肿瘤科
无进展生存期
卵巢癌
内科学
毒性
总体生存率
癌症
作者
M-P. Barretina-Ginesta,Bradley J. Monk,Samuel Han,Bhavana Pothuri,Annika Auranen,Dana M. Chase,Domenica Lorusso,Charles Anderson,Sophie Abadie‐Lacourtoisie,Noelle Cloven,Elena Ioana Braicu,Amit Agrawal,Andrés Redondo,Ruchit Shah,Nehemiah Kebede,Carol Hawkes,Dhiraj Gupta,Tatia Woodward,David M. O’Malley,Andrew Martin
PDF的下载单位、IP信息已删除
(2025-6-4)
浮游
卡皮巴拉yuan
无极微光
Criminology34
易点邦
香蕉诗蕊
专注的问寒
Twonej
BowieHuang
罗美女
棋士
sswbzh
彭于彦祖
pluto
stiger
kiminonawa
Adc
轨迹
Maestro_S
GingerF
spc68
ShawnJohn
niNe3YUE
乐空思
皖公网安备34019202002308
